{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:06:05Z","timestamp":1767888365249,"version":"3.49.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T00:00:00Z","timestamp":1388448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0083321","type":"journal-article","created":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T21:42:14Z","timestamp":1388526134000},"page":"e83321","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Subcomponent Vaccine Based on CTA1-DD Adjuvant with Incorporated UreB Class II Peptides Stimulates Protective Helicobacter pylori Immunity"],"prefix":"10.1371","volume":"8","author":[{"given":"John G.","family":"Nedrud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayer","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilda","family":"Bergroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dubravka Grdic","family":"Eliasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils Y.","family":"Lycke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,12,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","article-title":"<italic>Helicobacter pylori<\/italic> in peptic ulcer disease","volume":"272","year":"1994","journal-title":"Journal of the American Medical Association"},{"key":"ref2","unstructured":"World Health Organization (1994) Infection with <italic>Helicobacter pylori<\/italic>. Schistosomes, Liver Flukes and <italic>Helicobacter pylori<\/italic>. Lyon: International Agency for Research on Cancer. pp. 177\u2013241."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of <italic>Helicobacter pylori<\/italic> infection\u2013the Maastricht IV\/Florence Consensus Report","volume":"61","author":"P Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1523-5378.2012.00981.x","article-title":"Treatment of <italic>Helicobacter pylori<\/italic> infection 2012","volume":"17 Suppl 1","author":"B Tepes","year":"2012","journal-title":"Helicobacter"},{"key":"ref5","unstructured":"Blanchard TG, Nedrud JG (2010) <italic>Helicobacter pylori<\/italic> Vaccines. In: Sutton P, Mitchell H, editors. <italic>Helicobacter Pylori<\/italic> in the 21st Century. Wallingford, Oxfordshire United Kingdom: CAB International. pp. 167\u2013189."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrgastro.2011.1","article-title":"Vaccinating against <italic>Helicobacter pylori<\/italic> infection","volume":"8","author":"SJ Czinn","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/IAI.71.2.910-921.2003","article-title":"Vaccine-Induced Reduction of <italic>Helicobacter pylori<\/italic> Colonization in Mice Is Interleukin-12 Dependent but Gamma Interferon and Inducible Nitric Oxide Synthase Independent","volume":"71","author":"CA Garhart","year":"2003","journal-title":"Infect Immun"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1128\/IAI.00536-10","article-title":"Sublingual immunization protects against <italic>Helicobacter pylori<\/italic> infection and induces T and B cell responses in the stomach","volume":"78","author":"S Raghavan","year":"2010","journal-title":"Infect Immun"},{"key":"ref9","unstructured":"Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud JG, et al. (1998) MHC-class II but not MHC-class I or B cell responses are required for vaccine-induced protection against murine <italic>Helicobacter pylori<\/italic> infection. Abstracts to Third International Workshop on Pathogenesis and Host Response in Helicozbcter Infections, Helsingor, Denmark."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/cimm.1998.1421","article-title":"Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice","volume":"191","author":"TG Blanchard","year":"1999","journal-title":"Cellular Immunology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/IAI.67.1.337-341.1999","article-title":"<italic>Helicobacter pylori<\/italic> Infection in Immunized Mice Lacking Major Histocompatibility Complex Class I and Class II Functions","volume":"67","author":"J Pappo","year":"1999","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1440-1711.2000.00881.x","article-title":"Therapeutic immunization against <italic>Helicobacter pylori<\/italic> infection in the absence of antibodies","volume":"78","author":"P Sutton","year":"2000","journal-title":"Immunol Cell Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.4049\/jimmunol.172.8.5024","article-title":"<italic>Helicobacter pylori<\/italic>-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection","volume":"172","author":"AA Akhiani","year":"2004","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0016-5085(95)90275-9","article-title":"Oral immunization with <italic>Helicobacter pylori<\/italic> urease B subunit as a treatment against Helicobacter infection in mice","volume":"109","author":"I Corthesy-Theulaz","year":"1995","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0264-410X(97)00247-8","article-title":"Protection of mice against gastric colonization by <italic>Helicobacter pylori<\/italic> by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B","volume":"16","author":"OG Gomez-Duarte","year":"1998","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.vaccine.2004.07.037","article-title":"Poliovirus replicons encoding the B subunit of <italic>Helicobacter pylori<\/italic> urease protect mice against <italic>H. pylori<\/italic> infection","volume":"23","author":"LE Smythies","year":"2005","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1128\/IAI.69.11.6597-6603.2001","article-title":"Identification of an antigenic epitope in <italic>Helicobacter pylori<\/italic> urease that induces neutralizing antibody production","volume":"69","author":"K Hirota","year":"2001","journal-title":"Infect Immun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.vaccine.2006.12.024","article-title":"Identification of H-2d restricted Th epitopes in Urease B subunit of <italic>Helicobacter pylori<\/italic>","volume":"25","author":"Y Shi","year":"2007","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(99)70063-6","article-title":"Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in <italic>Helicobacter pylori<\/italic>-infected adults","volume":"116","author":"P Michetti","year":"1999","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0264-410X(97)00153-9","article-title":"Protection against <italic>Helicobacter pylori<\/italic> infection in mice by intragastric vaccination with <italic>H. pylori<\/italic> antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant","volume":"16","author":"M Marchetti","year":"1998","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.vaccine.2009.10.147","article-title":"Toward the development of a stable, freeze-dried formulation of <italic>Helicobacter pylori<\/italic> killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin","volume":"28","author":"NA Summerton","year":"2010","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.162.4.2432","article-title":"Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosylatransferase and Ig-binding activity","volume":"162","author":"LC \u00c5gren","year":"1999","journal-title":"Journal of Immunology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.4049\/jimmunol.158.8.3936","article-title":"Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit","volume":"158","author":"LC \u00c5gren","year":"1997","journal-title":"Journal of Immunology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.4049\/jimmunol.173.5.3310","article-title":"The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues","volume":"173","author":"AM Eriksson","year":"2004","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1099\/vir.0.2008\/005470-0","article-title":"CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization","volume":"89","author":"C Sundling","year":"2008","journal-title":"J Gen Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-3083.2005.01713.x","article-title":"The nontoxic CTA1-DD adjuvant enhances protective immunity against <italic>Helicobacter pylori<\/italic> infection following mucosal immunization","volume":"63","author":"AA Akhiani","year":"2006","journal-title":"Scand J Immunol"},{"key":"ref27","article-title":"Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins","author":"N Lycke","year":"2010","journal-title":"Mucosal Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.vaccine.2007.12.027","article-title":"CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine","volume":"26","author":"DG Eliasson","year":"2008","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1016\/j.vaccine.2011.03.090","article-title":"A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus","volume":"29","author":"DG Eliasson","year":"2011","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"8B.1.1","DOI":"10.1002\/9780471729259.mc08b01s24","article-title":"Laboratory Maintenance of Helicobacter Species","volume":"24","author":"TG Blanchard","year":"2012","journal-title":"Current Protocols in Microbiology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","article-title":"Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses","volume":"17","author":"S Nakae","year":"2002","journal-title":"Immunity"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(97)70155-0","article-title":"A standardised mouse model of <italic>Helicobacter pylori<\/italic> infection. Introducing the Sydney strain","volume":"112","author":"A Lee","year":"1997","journal-title":"Gastroenterology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1128\/IAI.70.7.3529-3538.2002","article-title":"Clearance of <italic>Helicobacter pylori<\/italic> infection and resolution of post immunization gastritis in a kinetic study of prophylactically immunized mice","volume":"70","author":"CA Garhart","year":"2002","journal-title":"Infection and Immunity"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.gastro.2008.09.017","article-title":"Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent","volume":"136","author":"ES DeLyria","year":"2009","journal-title":"Gastroenterology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.1016\/j.vaccine.2007.08.034","article-title":"Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against <italic>H. pylori<\/italic> infection in BALB\/c mice","volume":"25","author":"W Zhao","year":"2007","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/MMBR.56.4.622-647.1992","article-title":"Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin","volume":"56","author":"BD Spangler","year":"1992","journal-title":"Microbiological Reviews"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1523-5378.2011.00839.x","article-title":"Vaccine-Induced Immunity Against <italic>Helicobacter pylori<\/italic> in the Absence of IL-17A","volume":"16","author":"ES Delyria","year":"2011","journal-title":"Helicobacter"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1128\/IAI.00756-10","article-title":"Proinflammatory Cytokine Gene Expression in the Stomach Correlates with Vaccine-Induced Protection against <italic>Helicobacter pylori<\/italic> Infection in Mice: an Important Role for Interleukin-17 during the Effector Phase","volume":"79","author":"C-F Flach","year":"2011","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1053\/j.gastro.2009.02.077","article-title":"Interleukin 17 is a Critical Mediator of Vaccine-Induced reduction of Helicobacter infection in the mouse model","volume":"136","author":"D Velin","year":"2009","journal-title":"Gastroenterology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1586\/erv.13.20","article-title":"Why can&apos;t we make an effective vaccine against <italic>Helicobacter pylori<\/italic>","volume":"12","author":"P Sutton","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1286-4579(03)00125-4","article-title":"The quest for a vaccine against <italic>Helicobacter pylori<\/italic>\/how to move from mouse to man","volume":"5","author":"P Ruggiero","year":"2003","journal-title":"Microbes Infect"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2008.05.054","article-title":"Safety and immunogenicity of an intramuscular <italic>Helicobacter pylori<\/italic> vaccine in noninfected volunteers: a phase I study","volume":"135","author":"P Malfertheiner","year":"2008","journal-title":"Gastroenterology"},{"key":"ref43","article-title":"Key host-pathogen interactions for designing novel interventions against <italic>Helicobacter pylori<\/italic>","author":"AL Every","year":"2013","journal-title":"Trends Microbiol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.vaccine.2010.11.088","article-title":"A truncated form of HpaA is a promising antigen for use in a vaccine against <italic>Helicobacter pylori<\/italic>","volume":"29","author":"CF Flach","year":"2011","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.vaccine.2012.12.058","article-title":"Identification of two novel immunodominant UreB CD4(+) T cell epitopes in <italic>Helicobacter pylori<\/italic> infected subjects","volume":"31","author":"WC Yang","year":"2013","journal-title":"Vaccine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1016\/j.vaccine.2009.05.009","article-title":"Therapeutic efficacy of a multi-epitope vaccine against <italic>Helicobacter pylori<\/italic> infection in BALB\/c mice model","volume":"27","author":"WY Zhou","year":"2009","journal-title":"Vaccine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e69384","DOI":"10.1371\/journal.pone.0069384","article-title":"Th1-Mediated Immunity against <italic>Helicobacter pylori<\/italic> Can Compensate for Lack of Th17 Cells and Can Protect Mice in the Absence of Immunization","volume":"8","author":"H Ding","year":"2013","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0083321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T11:24:41Z","timestamp":1688901881000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0083321"}},"subtitle":[],"editor":[{"given":"Paulo Lee","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,31]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0083321","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,31]]}}}